Skip to content

Verification test of the effectiveness to alcohol metabolism by the intake of the beverage containing moromi lactic acid fermented

Verification test of the effectiveness to alcohol metabolism by the intake of the beverage containing moromi lactic acid fermented - alcohol metabolism by the intake of the beverage containing moromi lactic acid fermented

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000036493
Enrollment
15
Registered
2019-04-13
Start date
2019-04-13
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adult

Interventions

Moromi lactic acid fermented product containing beverage Placebo beverage

Sponsors

Medical Corporation Kenshokai
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Adult male at the age of 20 to 60 at the time of obtaining consent (2) Person who can drink diluted awamori (Alcohol content less than about 30%) (3) Person who was judged as "thin erythema" or "no erythema" by alcohol patch test (4) Person who weighs 50.0 kg to 90.0 kg (5) Persons with physique index (BMI) of 18.5 to 29.9 at the time of obtaining consent (6) Persons who are judged to have no problem in participation in this study (7) Persons who obtain written consent to participate in the trial

Exclusion criteria

Exclusion criteria: 1) Person who can not drink (2) Intakes of food and health food that are described as containing ingredients related to the test food: Moromi vinegar (3) Those who regularly use medicines, health food, food for specified health use, food with functional indication that may affect liver function (4) Those who regularly take health supplements and supplements related to immune function (5) Night shift workers and shift workers (6) At the time of obtaining consent, those who receive treatment (hormone replacement therapy, drug therapy, exercise therapy, diet therapy, etc.) at medical institutions etc. for treatment or prevention of disease etc. or conditions that require treatment Person to be judged (7) A person who is deemed to be inappropriate for the study participation

Design outcomes

Primary

MeasureTime frame
Blood ethanol, Blood Acetaldehyde

Secondary

MeasureTime frame
expiration ethanol

Countries

Japan

Contacts

Public ContactUema Tyoryo

ISHIKAWA SHUZOJO Co. Ltd. Production department

uemac@kamejikomi.com098-945-3515

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026